In our validation cohort of 154 PCa patients, immunostaining with p-JNK antibody revealed that higher p-JNK expression was associated with a shorter time to biochemical recurrence, highlighting a potential role of p-JNK upregulation in tumor progression. This evidence concerns the gene MAPK8 and posterior cortical atrophy.